IRIS Accounts Production v26.2.0.494 10246838 Board of Directors Board of Directors 31.12.25 1.1.25 31.12.25 31.12.25 true false true false false true false Ordinary 0 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh102468382024-12-31102468382025-12-31102468382025-01-012025-12-31102468382023-12-31102468382024-01-012024-12-31102468382024-12-3110246838ns15:EnglandWales2025-01-012025-12-3110246838ns14:PoundSterling2025-01-012025-12-3110246838ns10:Director12025-01-012025-12-3110246838ns10:Director22025-01-012025-12-3110246838ns10:Consolidated2025-12-3110246838ns10:ConsolidatedGroupCompanyAccounts2025-01-012025-12-3110246838ns10:PrivateLimitedCompanyLtd2025-01-012025-12-3110246838ns10:Consolidatedns10:SmallEntities2025-01-012025-12-3110246838ns10:Consolidatedns10:AuditExemptWithAccountantsReport2025-01-012025-12-3110246838ns10:SmallCompaniesRegimeForDirectorsReport2025-01-012025-12-3110246838ns10:SmallCompaniesRegimeForAccounts2025-01-012025-12-3110246838ns10:Consolidatedns10:SmallCompaniesRegimeForDirectorsReport2025-01-012025-12-3110246838ns10:Consolidatedns10:SmallCompaniesRegimeForAccounts2025-01-012025-12-3110246838ns10:FullAccounts2025-01-012025-12-3110246838ns10:OrdinaryShareClass12025-01-012025-12-3110246838ns10:Consolidated2025-01-012025-12-3110246838ns10:RegisteredOffice2025-01-012025-12-3110246838ns10:Consolidated2024-01-012024-12-3110246838ns5:CurrentFinancialInstruments2025-12-3110246838ns5:CurrentFinancialInstruments2024-12-3110246838ns5:Non-currentFinancialInstruments2025-12-3110246838ns5:Non-currentFinancialInstruments2024-12-3110246838ns5:ShareCapital2025-12-3110246838ns5:ShareCapital2024-12-3110246838ns5:RetainedEarningsAccumulatedLosses2025-12-3110246838ns5:RetainedEarningsAccumulatedLosses2024-12-3110246838ns5:PlantMachinery2025-01-012025-12-3110246838ns5:WithinOneYearns5:CurrentFinancialInstruments2025-12-3110246838ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3110246838ns10:OrdinaryShareClass12025-12-31
















NEILMED HOLDING COMPANY LIMITED

REPORT OF THE DIRECTORS AND

UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025






NEILMED HOLDING COMPANY LIMITED (REGISTERED NUMBER: 10246838)






CONTENTS OF THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025




Page

Company Information 1

Report of the Directors 2

Consolidated Income Statement 3

Consolidated Balance Sheet 4

Company Balance Sheet 6

Notes to the Consolidated Financial Statements 8


NEILMED HOLDING COMPANY LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2025







DIRECTORS: Dr K Mehta
Ms. N Mehta





REGISTERED OFFICE: 221 Kenton Lane
Kenton
Harrow
Middlesex
HA3 8RP





REGISTERED NUMBER: 10246838 (England and Wales)





ACCOUNTANTS: Akshar & Company
Chartered Accountants
221 Kenton Lane
Harrow
Middlesex
HA3 8RP

NEILMED HOLDING COMPANY LIMITED (REGISTERED NUMBER: 10246838)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 DECEMBER 2025

The directors present their report with the financial statements of the company and the group for the year ended 31 December 2025.

PRINCIPAL ACTIVITY
sale of pharmaceutical products and investments in subsidiaries.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 January 2025 to the date of this report.

Dr K Mehta
Ms. N Mehta

DIRECTORS' RESPONSIBILITIES STATEMENT
The directors are responsible for preparing the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the group and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's and the group's transactions and disclose with reasonable accuracy at any time the financial position of the company and the group and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:





Dr K Mehta - Director


21 August 2026

NEILMED HOLDING COMPANY LIMITED (REGISTERED NUMBER: 10246838)

CONSOLIDATED
INCOME STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2025

2025 2024
Notes £    £   

TURNOVER 5,873,505 11,688,585

Cost of sales 2,969,327 4,865,596
GROSS PROFIT 2,904,178 6,822,989

Administrative expenses 2,851,176 6,504,018
OPERATING PROFIT 4 53,002 318,971

Interest receivable and similar income 100 22
PROFIT BEFORE TAXATION 53,102 318,993

Tax on profit 47,629 89,738
PROFIT FOR THE FINANCIAL YEAR 5,473 229,255

Profit attributable to:
Owners of the parent 5,473 229,255

NEILMED HOLDING COMPANY LIMITED (REGISTERED NUMBER: 10246838)

CONSOLIDATED BALANCE SHEET
31 DECEMBER 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 6 204,325 277,577

CURRENT ASSETS
Stocks 1,686,774 2,520,477
Debtors 7 1,601,263 3,317,086
Cash at bank and in hand 364,122 1,288,792
3,652,159 7,126,355
CREDITORS
Amounts falling due within one year 9 3,157,506 3,467,749
NET CURRENT ASSETS 494,653 3,658,606
TOTAL ASSETS LESS CURRENT LIABILITIES 698,978 3,936,183

CREDITORS
Amounts falling due after more than one year 10 681,865 76,859
NET ASSETS 17,113 3,859,324

CAPITAL AND RESERVES
Called up share capital 11 100 100
Retained earnings 17,013 3,859,224
SHAREHOLDERS' FUNDS 17,113 3,859,324

The company and the group are entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2025.

The members have not required the company and the group to obtain an audit of its financial statements for the year ended 31 December 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a) ensuring that the group keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b) preparing financial statements which give a true and fair view of the state of affairs of the company and the group as at the end of each financial year and of the group's profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company and the group.

NEILMED HOLDING COMPANY LIMITED (REGISTERED NUMBER: 10246838)

CONSOLIDATED BALANCE SHEET - continued
31 DECEMBER 2025


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 21 August 2026 and were signed on its behalf by:




Dr K Mehta - Director



Ms. N Mehta - Director


NEILMED HOLDING COMPANY LIMITED (REGISTERED NUMBER: 10246838)

COMPANY BALANCE SHEET
31 DECEMBER 2025

2025 2024
Notes £    £   
CURRENT ASSETS
Debtors 7 727,458 1,196,552
Investments 8 6,575 6,643
Cash at bank and in hand 603 3,164
734,636 1,206,359
CREDITORS
Amounts falling due within one year 9 2,643 10,575
NET CURRENT ASSETS 731,993 1,195,784
TOTAL ASSETS LESS CURRENT LIABILITIES 731,993 1,195,784

CREDITORS
Amounts falling due after more than one year 10 661,492 -
NET ASSETS 70,501 1,195,784

CAPITAL AND RESERVES
Called up share capital 11 100 100
Retained earnings 70,401 1,195,684
SHAREHOLDERS' FUNDS 70,501 1,195,784

Company's profit for the financial year 2,722,401 16,763

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

NEILMED HOLDING COMPANY LIMITED (REGISTERED NUMBER: 10246838)

COMPANY BALANCE SHEET - continued
31 DECEMBER 2025


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 21 August 2026 and were signed on its behalf by:




Dr K Mehta - Director



Ms. N Mehta - Director


NEILMED HOLDING COMPANY LIMITED (REGISTERED NUMBER: 10246838)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

1. STATUTORY INFORMATION

Neilmed Holding Company Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the General Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Consolidated Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The group operates a defined contribution pension scheme. Contributions payable to the group's pension scheme are charged to profit or loss in the period to which they relate.

NEILMED HOLDING COMPANY LIMITED (REGISTERED NUMBER: 10246838)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 12 (2024 - 27 ) .

4. OPERATING PROFIT

The operating profit is stated after charging:

2025 2024
£    £   
Depreciation - owned assets 125,503 184,057

5. INDIVIDUAL INCOME STATEMENT

As permitted by Section 408 of the Companies Act 2006, the Income Statement of the parent company is not presented as part of these financial statements.


6. TANGIBLE FIXED ASSETS

Group
Fixtures
Long Plant and and
leasehold machinery fittings
£    £    £   
COST
At 1 January 2025 522,655 46,063 5,082
Additions 72,550 - -
Disposals (99,305 ) - -
At 31 December 2025 495,900 46,063 5,082
DEPRECIATION
At 1 January 2025 291,716 25,183 2,098
Charge for year 116,808 2,965 476
Eliminated on disposal (79,006 ) - -
At 31 December 2025 329,518 28,148 2,574
NET BOOK VALUE
At 31 December 2025 166,382 17,915 2,508
At 31 December 2024 230,939 20,880 2,984

NEILMED HOLDING COMPANY LIMITED (REGISTERED NUMBER: 10246838)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

6. TANGIBLE FIXED ASSETS - continued

Group

Motor Computer
vehicles equipment Totals
£    £    £   
COST
At 1 January 2025 54,290 1,350 629,440
Additions - - 72,550
Disposals - - (99,305 )
At 31 December 2025 54,290 1,350 602,685
DEPRECIATION
At 1 January 2025 31,516 1,350 351,863
Charge for year 5,254 - 125,503
Eliminated on disposal - - (79,006 )
At 31 December 2025 36,770 1,350 398,360
NET BOOK VALUE
At 31 December 2025 17,520 - 204,325
At 31 December 2024 22,774 - 277,577

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
2025 2024 2025 2024
£    £    £    £   
Trade debtors 1,428,412 3,152,292 727,458 1,196,552
Other debtors 172,851 164,794 - -
1,601,263 3,317,086 727,458 1,196,552

8. CURRENT ASSET INVESTMENTS

Company
2025 2024
£    £   
Shares in group undertakings 6,575 6,643

NEILMED HOLDING COMPANY LIMITED (REGISTERED NUMBER: 10246838)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

9. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
2025 2024 2025 2024
£    £    £    £   
Trade creditors 171,746 578,159 - -
Amounts owed to group undertakings - - 6,575 6,643
Taxation and social security 4,148 261,699 (3,932 ) 3,932
Other creditors 2,981,612 2,627,891 - -
3,157,506 3,467,749 2,643 10,575

10. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

Group Company
2025 2024 2025 2024
£    £    £    £   
Amounts owed to group undertakings 661,492 - 661,492 -
Other creditors 20,373 76,859 - -
681,865 76,859 661,492 -

11. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
100 Ordinary £1 100 100